Glucose-Lösung Deltamedica

Glucose-Lösung Deltamedica is an intravenous solution containing the carbohydrate glucose as its sole active ingredient. It is supplied as a sterile solution for injection, intended for parenteral administration in clinical settings across the EU. The product provides an immediate source of energy and helps maintain plasma osmolarity when delivered intravenously, supporting patients who require carbohydrate replacement or fluid balance management under medical supervision and monitoring.

Glucose-Lösung Deltamedica is used in several clinical situations where rapid carbohydrate delivery or fluid replacement is required.

- Treatment of acute hypoglycemia when oral glucose is not feasible. - Component of total parenteral nutrition (TPN) regimens for patients unable to receive enteral feeding. - Support of fluid and electrolyte balance during peri‑operative care. - Provision of an energy source during prolonged fasting or critical illness. - Adjunct in electrolyte replacement solutions to maintain osmotic stability.

Intravenous glucose solutions may be associated with a range of adverse reactions, most of which are related to the infusion rate or patient‑specific factors.

Common: - Transient mild hyperglycemia. - Local irritation or pain at the infusion site. - Nausea or mild gastrointestinal discomfort. - Headache. - Electrolyte shifts such as mild hyponatremia. - Flushing or warmth sensation.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Hypoglycemia after abrupt discontinuation of infusion. - Fluid overload or pulmonary edema. - Allergic or anaphylactoid reaction. - Hyperosmolar hyperglycemic state. - Severe electrolyte disturbances (e.g., hyperkalemia).

When administering Glucose-Lösung Deltamedica, clinicians should observe several safety considerations to minimize risk.

- Verify patient’s blood glucose level before initiating therapy. - Adjust infusion rate in patients with renal or cardiac impairment. - Monitor serum electrolytes regularly during prolonged use. - Use aseptic technique to prevent catheter‑related infections. - Avoid rapid bolus administration unless specifically indicated. - Consider pregnancy status; data are limited, so use only if benefits outweigh risks. - Document infusion parameters and patient response in the medical record.

Glucose-Lösung Deltamedica can interact with other medications or clinical conditions, requiring careful management.

Avoid: - Concurrent administration of high‑dose insulin without glucose monitoring. - Co‑infusion with hypertonic saline solutions that may exacerbate hyperosmolarity. - Use in patients with uncontrolled diabetes mellitus.

Use with caution: - Diuretics that may alter fluid balance. - Beta‑blockers that can mask hypoglycemia symptoms. - Corticosteroids, which can increase glucose production. - Catecholamine vasopressors that may affect glucose metabolism. - Nutritional formulas containing additional carbohydrates.